A new grading system for oral pemphigus

International Journal of Dermatology

Volumn 42, Issue 5, 2003, Pages 413-414

  Saraswat, Abir ^a   Kumar, Bhushan ^a  

^a NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

CLINICAL OBSERVATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; EATING HABIT; HUMAN; LETTER; MEDICAL ASSESSMENT; MOUTH MUCOSA; MOUTH PEMPHIGUS; MUCOSA INFLAMMATION; PATIENT SATISFACTION; PEMPHIGUS; PEMPHIGUS VULGARIS; REPRODUCIBILITY; SCORING SYSTEM; VALIDATION PROCESS;

HUMANS; MOUTH DISEASES; PEMPHIGUS; SEVERITY OF ILLNESS INDEX;

EID: 0038543051     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2003.01811.x     Document Type: Letter

References (8)

1. Krain LS. Pemphigus. Arch Dermatol 1974; 110: 862-865.
2. Scully C. The oral cavity. In: Champion RH, Burton JL, Burns DA, Breathnach SM, eds. Textbook of Dermatology. Oxford: Blackwell Science 1998, 3083-3084.
3. Ishii K, Amagai M, Hall RP, et al. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with Baculovirus-expressed recombinant desmogleins. J Immunol 1997; 159: 2010-2017.
4. Harman KE, Seed PT, Gratian MJ, Bhogal BS, Challacombe SJ, Black MM. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol 2001; 144: 775-780.
5. Agarwal M, Walia R, Kochhar AM, Chander R. Pemphigus Area and Activity Score (PAAS) - A novel clinical scoring method for monitoring of pemphigus vulgaris patients. Int J Dermatol 1998; 37: 158-160.
6. Dakkak K, Bennett JR. A new dysphagia score with objective validation. J Clin Gastroenterol 1992; 14: 99-100.
7. Becker BA, Gaspari AA. Pemphigus vulgaris and vegetans. Dermatol Clin 1993; 11: 429-452.
8. Pasricha JS, Das SS. Curative effect of dexamethasone-cyclophosphamide pulse therapy for the treatment of pemphigus vulgaris. Int J Dermatol 1992; 31: 875-879.